Related Experiment Video

Updated: Jul 17, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Differential oncogenic potential of activated RAS isoforms in melanocytes

T Whitwam1, M W Vanbrocklin, M E Russo

  • 1Molecular Medicine and Virology Group, Van Andel Research Institute, Grand Rapids, MI, USA.

Oncogene
|February 14, 2007
PubMed

Insights

RAS gene mutations drive 30% of cancers. In melanoma, NRAS mutations are common, unlike HRAS and KRAS, due to NRAS enhancing MYC activity and promoting proliferation, offering insights into cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RAS genes are frequently mutated in human cancers, but specific RAS isoforms show tissue-specific mutation biases.
  • NRAS mutations are prevalent in melanoma, while HRAS and KRAS mutations are rare in this cancer type.

Purpose of the Study:

  • To investigate the mechanistic basis for the preferential mutation of NRAS over KRAS in melanocytes.
  • To compare the transformation efficiencies and signaling activities of mutant NRAS and KRAS in a relevant cellular context.

Main Methods:

  • Utilized immortal, non-transformed Ink4a/Arf-deficient melanocytes.
  • Compared the transformation efficiencies of NRAS and KRAS mutations.
  • Assessed cellular proliferation, tumorigenicity, and signaling pathway activation (MAPK, MYC).

Main Results:

  • NRAS mutation significantly increased melanocyte proliferation and was potently tumorigenic.
  • KRAS mutation did not enhance melanocyte proliferation and exhibited weak tumorigenicity.
  • Both NRAS and KRAS activated MAPK signaling, but only NRAS enhanced MYC activity.

Conclusions:

  • RAS isoform activity is context-dependent, explaining the prevalence of NRAS mutations in melanoma.
  • The findings provide a mechanistic rationale for NRAS-specific mutations in melanoma.
  • Understanding these mechanisms has implications for developing targeted cancer therapies for RAS-driven cancers.

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...